JT
INBX icon

Jupiter Topco’s Inhibrx INBX Stock Holding History

Jupiter Topco’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$322K Buy
+3,400
New +$341K ﹤0.01% 2281

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jupiter Topco's INBX Position: Q2 2026 in Review

Jupiter Topco opened a new position in Inhibrx (INBX) in Q2 2026: 3,400 shares worth $322K. The stake represents ﹤0.01% of the portfolio and ranks #2281 among its holdings.

148 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Jupiter Topco held 3,400 shares of Inhibrx worth $322K as of Q2 2026.
  • Inhibrx was a new Jupiter Topco position in Q2 2026.
  • Inhibrx made up ﹤0.01% of Jupiter Topco's portfolio in Q2 2026, its #2281 holding.
  • 148 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.